A Clinical Trial of Multiple Doses of GR2301 Injection in Healthy Adult Trial Participants in China.

Clinical trial NCT07647224 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07647224
Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Dose Healthy Adult Participants

Start date: 2026-06-01
Primary completion: 2027-07-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.